Literature DB >> 24327199

[Modern, minimally invasive surgery of the lacrimal duct system].

S Amin1, K H Emmerich, H-W Meyer-Rüsenberg.   

Abstract

Epiphora (tearing) is the main symptom of a dysfunction of the lacrimal drainage. Tearing is a common problem and the cause can not easily be identified. Since development and miniaturisation of gastroduodenal endoscopes in the 1990s, it is possible to check the anatomical structure and the pathological changes of the lacrimal drainage system, which has a diameter of 1 mm. Mechanical stenosis is often caused by recurring chronic inflammation. Complete stenosis is usually only punctual and seldom over a long distance. Shortly after the development of microendoscopic diagnostic tools, therapeutic techniques using a laser for the dacryoplasty (LDP) or a microdrill for the dacryoplasty (MDP) were established. For the first time, these treatments enable preservation of the whole physiology of the lacrimal drainage system in spite of surgical intervention.

Entities:  

Mesh:

Year:  2013        PMID: 24327199     DOI: 10.1007/s00106-013-2760-x

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  16 in total

1.  [Endoscopic laser dacryoplasty. Methodology and outcome after 3 months].

Authors:  H W Meyer-Rüsenberg; K H Emmerich; M Lüchtenberg; J Steinhauer
Journal:  Ophthalmologe       Date:  1999-05       Impact factor: 1.059

2.  [Endoscopic lacrimal duct surgery].

Authors:  K H Emmerich; H W Meyer-Rüsenberg
Journal:  Ophthalmologe       Date:  2001-07       Impact factor: 1.059

Review 3.  [Nasolacrimal ducts and the dry eye].

Authors:  F Paulsen; A Thale; U Schaudig
Journal:  Ophthalmologe       Date:  2002-07       Impact factor: 1.059

Review 4.  [Anatomy and physiology of efferent tear ducts].

Authors:  F Paulsen
Journal:  Ophthalmologe       Date:  2008-04       Impact factor: 1.059

Review 5.  [Treatment of lacrimal stenosis. Causes, diagnostics, and surgical procedures].

Authors:  M B Bloching; J Prescher
Journal:  Ophthalmologe       Date:  2009-03       Impact factor: 1.059

6.  [Therapy options for diseases of the lacrimal ducts].

Authors:  H-W Meyer-Rüsenberg; K-H Emmerich
Journal:  Ophthalmologe       Date:  2009-03       Impact factor: 1.059

7.  [Endoscopy of the lacrimal ducts].

Authors:  K H Emmerich; H W Meyer-Rüsenberg; P Simko
Journal:  Ophthalmologe       Date:  1997-10       Impact factor: 1.059

8.  [Dacryoendoscopy--current status].

Authors:  K H Emmerich; J Steinhauer; H W Meyer-Rüsenberg; M Lüchtenberg
Journal:  Ophthalmologe       Date:  1998-12       Impact factor: 1.059

Review 9.  [Interdisciplinary diagnostics for examination of lacrimal disorders].

Authors:  E Domeier; M Kühnemund; K H Wilhelm
Journal:  Ophthalmologe       Date:  2008-04       Impact factor: 1.059

10.  A simple and evolutional approach proven to recanalise the nasolacrimal duct obstruction.

Authors:  D Chen; J Ge; L Wang; Q Gao; P Ma; N Li; D-Q Li; Z Wang
Journal:  Br J Ophthalmol       Date:  2009-05-04       Impact factor: 4.638

View more
  5 in total

Review 1.  [Microendoscopic minimally invasive techniques in lacrimal surgery].

Authors:  K-H Emmerich; S Amin; H-W Meyer-Rüsenberg; R Ungerechts
Journal:  Ophthalmologe       Date:  2017-05       Impact factor: 1.059

2.  [Concretions and iatrogenic foreign bodies in the lacrimal system : Treatment recommendations].

Authors:  J Heichel; A Sandner; U Siebolts; D Bethmann; H-G Struck
Journal:  HNO       Date:  2016-06       Impact factor: 1.284

3.  [Modern, minimally invasive surgery of the lacrimal duct system].

Authors:  K H Emmerich; H-W Rüsenberg; S Amin
Journal:  Ophthalmologe       Date:  2014-09       Impact factor: 1.059

Review 4.  [Recognition and prevention of problems in lacrimal duct surgery].

Authors:  T Kühnel
Journal:  HNO       Date:  2018-06       Impact factor: 1.284

Review 5.  [Treatment of nasolacrimal duct obstruction from the otorhinolaryngologist's perspective].

Authors:  C Ginzkey; R Mlynski
Journal:  HNO       Date:  2016-06       Impact factor: 1.284

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.